Akari Therapeutics PLC (AKTX)
1.24
-0.23
(-15.65%)
USD |
NASDAQ |
Nov 21, 16:00
1.28
+0.04
(+3.23%)
After-Hours: 20:00
Akari Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| December 29, 2023 | 6.342 |
| December 28, 2023 | 6.097 |
| December 27, 2023 | 6.382 |
| December 26, 2023 | 6.118 |
| December 22, 2023 | 6.199 |
| December 21, 2023 | 6.199 |
| December 20, 2023 | 5.968 |
| December 19, 2023 | 5.996 |
| December 18, 2023 | 5.772 |
| December 15, 2023 | 5.691 |
| December 14, 2023 | 6.260 |
| December 13, 2023 | 5.914 |
| December 12, 2023 | 6.138 |
| December 11, 2023 | 6.097 |
| December 08, 2023 | 6.341 |
| December 07, 2023 | 6.402 |
| December 06, 2023 | 6.239 |
| December 05, 2023 | 6.768 |
| December 04, 2023 | 6.585 |
| December 01, 2023 | 6.565 |
| November 30, 2023 | 5.996 |
| November 29, 2023 | 6.058 |
| November 28, 2023 | 5.894 |
| November 27, 2023 | 5.914 |
| November 24, 2023 | 6.118 |
| Date | Value |
|---|---|
| November 22, 2023 | 6.097 |
| November 21, 2023 | 6.199 |
| November 20, 2023 | 6.646 |
| November 17, 2023 | 6.504 |
| November 16, 2023 | 6.565 |
| November 15, 2023 | 6.443 |
| November 14, 2023 | 6.506 |
| November 13, 2023 | 6.910 |
| November 10, 2023 | 6.870 |
| November 09, 2023 | 7.124 |
| November 08, 2023 | 7.154 |
| November 07, 2023 | 7.337 |
| November 06, 2023 | 7.489 |
| November 03, 2023 | 7.337 |
| November 02, 2023 | 7.195 |
| November 01, 2023 | 7.296 |
| October 31, 2023 | 6.931 |
| October 30, 2023 | 7.520 |
| October 27, 2023 | 7.317 |
| October 26, 2023 | 7.317 |
| October 25, 2023 | 7.317 |
| October 24, 2023 | 7.113 |
| October 23, 2023 | 6.971 |
| October 20, 2023 | 6.910 |
| October 19, 2023 | 7.215 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.341
Minimum
Mar 30 2023
7221.70
Maximum
Mar 03 2020
357.77
Average
10.62
Median
Price to Book Value Benchmarks
| DBV Technologies SA | 0.8635 |
| Cellectis SA | 1.454 |
| Adaptimmune Therapeutics PLC | 2.028 |
| Biodexa Pharmaceuticals PLC | 0.2294 |
| NuCana PLC | 0.5936 |
Price to Book Value Related Metrics
| Price | 1.24 |
| Earnings Yield | -215.0% |
| Market Cap | 25.60M |